183 related articles for article (PubMed ID: 10796061)
1. Pharmacokinetics of sustained and immediate release formulations of indapamide after single and repeated oral administration in healthy volunteers.
Schiavi P; Jochemsen R; Guez D
Fundam Clin Pharmacol; 2000; 14(2):139-46. PubMed ID: 10796061
[TBL] [Abstract][Full Text] [Related]
2. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic comparison of sustained- and immediate-release oral formulations of cilostazol in healthy Korean subjects: a randomized, open-label, 3-part, sequential, 2-period, crossover, single-dose, food-effect, and multiple-dose study.
Lee D; Lim LA; Jang SB; Lee YJ; Chung JY; Choi JR; Kim K; Park JW; Yoon H; Lee J; Park MS; Park K
Clin Ther; 2011 Dec; 33(12):2038-53. PubMed ID: 22129569
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Tolerability Comparison of Sustained and Immediate Release Oral Formulations of Nifedipine Tablet Formulations: A Single-Dose, Randomized, Open-Label, Two-Period, Two-Way Crossover Study in Healthy, Fasting Egyptian Male Volunteers.
El-Masry SM; El-Khodary NM
Drug Res (Stuttg); 2020 Feb; 70(2-03):91-96. PubMed ID: 31746448
[TBL] [Abstract][Full Text] [Related]
5. Galenic development and pharmacokinetic profile of indapamide sustained release 1.5 mg.
Damien G; Huet de Barochez B; Schiavi P
Clin Pharmacokinet; 1999; 37 Suppl 1():13-9. PubMed ID: 10491729
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.
Jenner P; Könen-Bergmann M; Schepers C; Haertter S
Clin Ther; 2009 Nov; 31(11):2698-711. PubMed ID: 20110012
[TBL] [Abstract][Full Text] [Related]
7. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
8. Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations.
Bialer M; Sussan S; Abu Salach O; Danenberg HD; Ben-David J; Gibor Y; Laor A
J Pharm Sci; 1995 Oct; 84(10):1160-3. PubMed ID: 8801328
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
[TBL] [Abstract][Full Text] [Related]
10. Development, Physicochemical Characteristics and Pharmacokinetics of a New Sustained-Release Bilayer Tablet Formulation of Tramadol with an Immediate-Release Component for Twice-Daily Administration.
Ishitsubo N; Oguro S; Shimahashi H; Kawanishi M; Adachi T; Mitsuda K; Ishibashi N
Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):87-100. PubMed ID: 38064122
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and pharmacokinetics of a fixed combination of delapril/indapamide following single and multiple dosing in healthy volunteers.
Hutt V; Pabst G; Dilger C; Poli G; Acerbi D
Eur J Drug Metab Pharmacokinet; 1994; 19(1):59-69. PubMed ID: 7957454
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic comparison of sustained- and immediate-release formulations of cilostazol after multiple oral doses in fed healthy male Korean volunteers.
Kim YH; Ghim JL; Jung JA; Cho SH; Choe S; Choi HY; Bae KS; Lim HS
Drug Des Devel Ther; 2015; 9():3571-7. PubMed ID: 26185423
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.
Göhler K; Brett M; Smit JW; Rengelshausen J; Terlinden R
Int J Clin Pharmacol Ther; 2013 Apr; 51(4):338-48. PubMed ID: 23357834
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a New, Once-Daily, Sustained-release Pregabalin Tablet in Healthy Male Volunteers.
Moon SJ; Jeon JY; Lim Y; An T; Jang SB; Kim S; Na WS; Lee SY; Kim MG
Clin Ther; 2021 Aug; 43(8):1381-1391.e1. PubMed ID: 34256964
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy, safety and pharmacokinetics of verapamil SR vs verapamil IR in hypertensive patients.
Fuenmayor NT; Faggin BM; Cubeddu LX
Drugs; 1992; 44 Suppl 1():1-11. PubMed ID: 1283570
[TBL] [Abstract][Full Text] [Related]
16. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
Ambrosioni E; Safar M; Degaute JP; Malin PL; MacMahon M; Pujol DR; de Cordoüe A; Guez D
J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects.
Xu MJ; Zou C; H Chu J; Wu T; Liu SJ; Zhang J; Chen M; Liu F; Xiong NN; Ju WZ; S Tan H
Int J Clin Pharmacol Ther; 2011 Mar; 49(3):237-46. PubMed ID: 21329626
[TBL] [Abstract][Full Text] [Related]
18. Indapamide sustained release: a review of its use in the treatment of hypertension.
Robinson DM; Wellington K
Drugs; 2006; 66(2):257-71. PubMed ID: 16451099
[TBL] [Abstract][Full Text] [Related]
19. Comparative Pharmacokinetics of a Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and an Immediate-release Pregabalin Capsule in Healthy Male Volunteers.
Kim TE; Jeon JY; Gu N; Chang Kwon M; Kim MG
Clin Ther; 2018 Dec; 40(12):2112-2124. PubMed ID: 30497798
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Pharmacokinetics and Bioavailability of Fixed-Dose Combination Tablet and Monotherapy Combination of Allisartan Isoproxil and Indapamide Sustained-Release in Healthy Chinese Volunteers.
Fan N; Gongmin Z; Wenming C; Jiao Y; Ruijie Z; Yan C; Xiangming T; Yi W
Clin Pharmacol Drug Dev; 2024 Feb; 13(2):190-196. PubMed ID: 37691309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
